Difference between revisions of "US PA Philadelphia Falk MJ"
From Bioblast
| Line 11: | Line 11: | ||
|country=USA | |country=USA | ||
|Contact=Falk MJ | |Contact=Falk MJ | ||
|MiPNetLab=Polyak E | |||
|Status=O2k 2008 - | |||
|weblink=[http://www.med.upenn.edu/apps/faculty/index.php/g275/p8141835 Falk MJ] | |weblink=[http://www.med.upenn.edu/apps/faculty/index.php/g275/p8141835 Falk MJ] | ||
|keyword=Respiratory OXPHOS disease | |||
|keyword=Respiratory | |||
}} | }} | ||
* [[Talk:MiPNet_Reference_Laboratories#MiPNet Reference Laboratories - highlighted|MiPNet Reference Laboratory of the Week - 2012-05-06]] | * [[Talk:MiPNet_Reference_Laboratories#MiPNet Reference Laboratories - highlighted|MiPNet Reference Laboratory of the Week - 2012-05-06]] | ||
Revision as of 20:17, 8 February 2013
- We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ
Participated at
- IOC47
